A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma (STRASS 2)

Disease Sites:

Sarcoma

Staging:

Phase III

Age Group:

Adults

Therapies:

Chemotherapy - cytotoxic, Surgery

Drugs:

Dacarbazine (DTIC), Doxorubicin, Ifosfamide

Principal Investigator(s):

Davis, Elizabeth

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

05-16-2024

Trial Type:

Treatment

Protocol ID:

ECOGSAREA7211

National Clinical Trial ID:

NCT04031677

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available